How to Use an SBA Loan to Acquire a Pain Management Clinic
SBA 7(a) loans are one of the most powerful tools for financing a pain management practice acquisition in the $1M–$5M range. Here's exactly how to use them — and the healthcare-specific hurdles you must prepare for.
Find SBA-Eligible Pain Management Clinic BusinessesSBA Overview for Pain Management Clinic Acquisitions
Pain management clinics are among the most financeable healthcare businesses in the lower middle market, and SBA 7(a) loans are frequently used to fund acquisitions in the $1M–$5M revenue range. SBA-backed financing allows qualified buyers to acquire an established interventional pain or medication management practice with as little as 10% down, preserving working capital for post-close operations, credentialing costs, and staff retention. However, the healthcare regulatory environment — including DEA registration requirements, corporate practice of medicine restrictions, and payer contract assignability — adds meaningful complexity that standard SBA lenders may not fully understand. Buyers must work with SBA lenders experienced in healthcare acquisitions, structure the deal properly under applicable state law (often using an MSO model), and be prepared to document compliance history thoroughly. Done correctly, SBA financing enables entrepreneurial physicians, search fund operators, and PE-backed groups to acquire a cash-flowing pain practice with favorable long-term debt terms and a manageable equity requirement.
Down payment: Most SBA lenders require a minimum 10% equity injection for pain management clinic acquisitions. However, because pain practices frequently carry significant intangible goodwill tied to physician relationships, referral networks, and brand reputation, lenders experienced in healthcare will often require 15–20% down when goodwill represents the majority of the purchase price. On a $3M acquisition, that means a buyer should be prepared to bring $300,000–$600,000 in equity at close. This equity can come from personal funds, outside investors, or seller financing — and many deals in this space include a seller carry note of 10–15% of the purchase price, which SBA lenders may allow to count toward the equity requirement if the seller note is on full standby for the first 24 months. Deals involving a physician earnout or equity rollover by the selling physician can also reduce the upfront cash requirement while aligning incentives for post-close retention.
SBA Loan Options
SBA 7(a) Standard Loan
Loan terms up to 10 years for business acquisitions; fully amortizing with variable or fixed interest rates typically ranging from Prime + 2.25% to Prime + 2.75% depending on loan size and lender
$5,000,000
Best for: Full practice acquisitions including goodwill, equipment, patient records, and working capital; ideal for acquiring a pain management clinic with an established referral network and recurring interventional procedure revenue
SBA 7(a) Small Loan
Up to 10-year repayment term; streamlined underwriting with less documentation required; rates similar to standard 7(a) product
$500,000
Best for: Smaller pain clinic acquisitions, partial buyouts, or add-on acquisitions where the purchase price is under $500K and the buyer needs fast, flexible financing without the full underwriting burden of a standard loan
SBA 504 Loan
10, 20, or 25-year fixed-rate terms on the CDC portion; bank portion typically carries a 10-year term; below-market fixed rates on the CDC tranche
$5,500,000 (combined CDC and bank portions)
Best for: Acquisitions that include significant real estate or major capital equipment such as fluoroscopy suites, procedure room build-outs, or neuromodulation equipment; requires that at least 51% of proceeds go toward fixed assets rather than goodwill
Eligibility Requirements
- The acquiring entity must be a for-profit U.S. business and the pain management clinic being acquired must meet SBA small business size standards, generally defined as under $8M in annual receipts for outpatient specialty medical practices
- The buyer must inject a minimum of 10% equity as a down payment; for acquisitions where more than 50% of assets are goodwill — common in physician-dependent pain practices — lenders typically require 15–20% down to mitigate key-person risk
- The acquiring structure must comply with state corporate practice of medicine (CPOM) laws; in states with strict CPOM restrictions, buyers will need to establish a Management Services Organization (MSO) that contracts with a physician-owned professional corporation, and the SBA loan must be structured accordingly
- The practice must have a clean or resolvable regulatory history — DEA registration must be in good standing, with no unresolved opioid prescribing investigations, CMS reimbursement audits, or state medical board sanctions that would materially impair business operations post-close
- Existing payer contracts (Medicare, Medicaid, and commercial insurers) must be assignable or re-credentialing must be feasible within a reasonable post-close timeline; lenders will scrutinize revenue concentration risk and require evidence that reimbursement will continue under new ownership
- The buyer must demonstrate relevant management experience in healthcare operations or clinical practice management; lenders will typically require a licensed physician or credentialed clinical director to remain involved in day-to-day operations as a condition of financing
Step-by-Step Process
Define Your Acquisition Criteria and Legal Structure
Before approaching lenders, determine whether you are a physician buyer acquiring directly into a professional corporation, or a non-physician buyer who must use an MSO structure to comply with your state's corporate practice of medicine rules. Pain management clinics in most states cannot be owned by non-physicians without an MSO arrangement. Establish your target practice profile — ideally $1M–$5M in revenue, 20–35% EBITDA margins, diversified payer mix, at least one board-certified pain physician, and a clean DEA compliance record. Engaging a healthcare M&A attorney at this stage will save significant time and prevent deal-killing structural errors later.
Engage an SBA Lender With Healthcare M&A Experience
Not all SBA lenders are equipped to underwrite pain management clinic acquisitions. Look for banks or non-bank SBA lenders with a documented track record in healthcare practice financing. They will understand DEA registration transfer, payer credentialing timelines, and how to size the loan against normalized EBITDA rather than raw revenue. Prepare a borrower package that includes your personal financial statement, business plan, resume highlighting clinical or healthcare operations experience, and a letter of intent (LOI) on the target practice if available. Lenders will want to see that cash flow from the practice — after debt service — produces a debt service coverage ratio (DSCR) of at least 1.25x.
Submit a Letter of Intent and Begin Due Diligence
Once you have a target practice identified, execute a non-binding LOI outlining the purchase price, structure (asset vs. stock purchase), and key deal terms including any seller financing or earnout. Pain management acquisitions almost always close as asset purchases to avoid inheriting unknown DEA compliance liabilities, opioid litigation exposure, or legacy billing issues. Immediately begin due diligence on DEA registration status and opioid prescribing patterns, payer mix and contract assignability, revenue cycle health (denial rates, days in AR, coding accuracy), malpractice history, and physician employment agreements. Your SBA lender will conduct their own credit analysis in parallel using 3 years of business tax returns and financial statements from the seller.
Complete SBA Loan Application and Third-Party Reports
Submit the full SBA loan application to your lender, including the completed SBA Form 1919 (borrower information), Form 912 (personal history), and all supporting financial documentation. The lender will order a business valuation (required for most goodwill-heavy acquisitions), environmental report if real property is involved, and may require a healthcare compliance review or billing audit. Ensure the seller has 3 years of CPA-reviewed or audited financials available — lenders will not rely on internally prepared statements for practice acquisitions in this size range. Address any add-backs to EBITDA clearly and document their legitimacy (e.g., owner compensation above replacement cost, personal vehicle expenses, one-time legal fees).
Receive SBA Commitment and Finalize Deal Structure
Once the lender issues an SBA loan commitment letter, work with your healthcare M&A attorney to finalize the purchase agreement, transition any DEA registration, address payer contract assignments or re-credentialing requirements, and execute physician employment or consulting agreements for post-close continuity. If the structure involves an MSO, ensure the management services agreement is in place and compliant with fee-splitting laws in your state. Coordinate with the seller on a patient notification plan and physician transition communications to protect the recurring patient base that underpins the practice's value.
Close and Execute the Post-Acquisition Transition Plan
At closing, SBA loan proceeds are disbursed to fund the acquisition. Immediately activate your post-close plan: confirm DEA registration is transferred or re-issued in the new entity's name, re-credential the acquiring entity with all major payers (Medicare re-enrollment can take 60–90 days, so begin early), onboard staff under new employment agreements, and implement your revenue cycle management protocols. Retain a healthcare billing consultant if the seller's RCM infrastructure is weak. Monitor DSCR monthly and maintain open communication with your SBA lender — proactive reporting builds goodwill and protects your financing relationship if unexpected challenges arise in year one.
Common Mistakes
- ✗Failing to account for the DEA registration transfer timeline and assuming the existing DEA number conveys automatically in an asset purchase — it does not, and operating without a valid DEA registration in a pain management clinic can halt revenue from controlled substance prescribing, which is often central to the practice's service model
- ✗Using a generic SBA lender unfamiliar with healthcare regulations, resulting in loan conditions that don't account for payer credentialing gaps, MSO structure requirements, or the time lag between closing and when Medicare reimbursements begin flowing to the new entity — a critical cash flow risk in the first 90 days post-close
- ✗Underestimating the impact of opioid prescribing history during lender underwriting; if the target practice has a high volume of Schedule II prescriptions, prior DEA audits, or PDMP compliance issues, many SBA lenders will decline the deal entirely — buyers should surface this risk early and either address it pre-LOI or price it into the offer
- ✗Treating the business valuation as a formality rather than a strategic document; SBA lenders require a third-party business valuation for goodwill-heavy acquisitions, and if the appraised value comes in below the purchase price, the buyer must fund the gap with additional equity — buyers should engage a valuator experienced in medical practices before finalizing the LOI to avoid a surprise at the appraisal stage
- ✗Neglecting to verify payer contract assignability before closing; many commercial insurance contracts and Medicare provider agreements are not automatically transferable in an asset purchase and require re-credentialing that can take 60–120 days, creating a revenue gap post-close that must be funded through working capital — a reserve line or seller escrow holdback is often the appropriate mitigation
Lender Tips
- Seek out SBA Preferred Lender Program (PLP) lenders with a dedicated healthcare vertical — these lenders have in-house underwriters who understand pain management practice cash flows, recognize the difference between net collections and gross charges, and can structure around physician earnouts and MSO arrangements without requiring excessive time from your deal team
- Normalize EBITDA carefully and document every add-back with receipts or third-party support; lenders will apply heightened scrutiny to owner compensation add-backs in physician practices where the buyer intends to hire a replacement physician at market salary — be prepared to show the delta between seller W-2 and fair market replacement cost clearly in your loan package
- Request that the lender pre-approve the MSO or professional corporation structure before you finalize your deal documents; some SBA lenders have internal policies about lending to non-physician-owned entities in healthcare, and discovering this incompatibility after you've spent $20,000 on legal fees is a costly and avoidable mistake
- Build a cash reserve into your financing request to cover the credentialing gap period post-close; include a working capital line request alongside the term loan — some SBA lenders will combine a term acquisition loan with a revolving line of credit in a single SBA 7(a) package, which provides a safety net during the 60–90 day period before payer reimbursements normalize under the new entity
- Provide the lender with a detailed post-close physician retention plan, including signed employment agreements or letters of intent from the key pain physician(s); lenders financing goodwill-heavy medical practices will want evidence that the clinical revenue driver is contractually committed to remain post-close, as physician departure is the single largest risk to debt service coverage in a pain management acquisition
Find SBA-Ready Pain Management Clinic Businesses
Pre-screened acquisition targets with verified financials — free to join.
SBA Loan Calculator
Estimate your monthly payment for a Pain Management Clinic acquisition
Standard for acquisitions
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
Can a non-physician use an SBA loan to buy a pain management clinic?
Yes, but the structure must comply with your state's corporate practice of medicine (CPOM) laws. Most states prohibit non-physicians from directly owning a medical practice, but a non-physician buyer can establish a Management Services Organization (MSO) that acquires the business assets, real estate, and equipment, then enters into a management services agreement with a physician-owned professional corporation (PC) that employs the clinical staff and holds the medical licenses. The SBA loan is made to the MSO entity. You must work with a healthcare M&A attorney to ensure the MSO structure is properly documented and compliant with your state's fee-splitting and CPOM rules before submitting a loan application.
What EBITDA multiples do SBA lenders use to size loans for pain management clinic acquisitions?
SBA lenders typically underwrite pain management clinic acquisitions at 3.5x to 6x adjusted EBITDA, consistent with market multiples for established outpatient specialty practices in the $1M–$5M revenue range. The actual multiple depends on factors including payer mix quality, physician key-person risk, DEA compliance history, and revenue concentration. Lenders will calculate a debt service coverage ratio (DSCR) — generally requiring at least 1.25x — to confirm the practice generates enough normalized free cash flow to service the loan after paying a market-rate physician salary. If the purchase price implies a DSCR below 1.25x, you will need to increase your down payment to bring the loan balance down to a serviceable level.
How does the DEA registration transfer affect the SBA loan closing timeline?
In an asset purchase of a pain management clinic, the seller's DEA registration does not transfer to the buyer. The new entity must apply for its own DEA registration, which can take 4–8 weeks under normal circumstances. During this period, the new owner cannot prescribe or dispense Schedule II–V controlled substances, which may significantly impact revenue if medication management is a core part of the practice's service mix. Buyers and their attorneys often negotiate a transition services agreement allowing the selling physician to continue prescribing under their own DEA registration during the transition window, or structure the closing to coincide with DEA approval. SBA lenders should be informed of this timeline gap and working capital should be reserved accordingly.
Will a history of opioid prescribing or past DEA scrutiny kill my SBA loan application?
Not automatically, but it will significantly complicate underwriting. SBA lenders financing pain management practices are aware of the regulatory environment and will conduct enhanced due diligence on the practice's DEA compliance history, opioid prescribing patterns, and PDMP participation. A past DEA audit that was resolved cleanly with no sanctions may be acceptable to certain lenders with strong documentation. However, active DEA investigations, unresolved sanctions, history of DEA registration revocation or surrender, or patterns of high-volume Schedule II prescribing inconsistent with clinical norms will likely result in loan denial from most conventional SBA lenders. Buyers should order a compliance audit of the target's opioid prescribing records before submitting a loan application to identify and address any issues proactively.
How long does it take to close a pain management clinic acquisition using SBA financing?
A typical SBA-financed pain management clinic acquisition takes 90–180 days from signed LOI to close, depending on deal complexity, lender processing times, DEA registration timing, and payer credentialing requirements. The SBA loan underwriting and approval process alone takes 45–90 days. Healthcare-specific steps including payer contract assignment review, DEA transfer planning, physician employment agreement negotiation, and state licensing verification add additional time compared to non-healthcare business acquisitions. Buyers should build a realistic timeline into their LOI exclusivity period — typically 90–120 days — and engage an SBA lender and healthcare M&A attorney simultaneously at the LOI stage to run workstreams in parallel and minimize delays.
Can seller financing count toward the SBA down payment requirement for a pain clinic?
Yes, in many cases seller financing can be structured to satisfy part of the SBA equity injection requirement. The SBA typically allows seller notes to count toward the equity requirement if the seller note is on full standby — meaning no payments of principal or interest — for the first 24 months following close, and the seller does not retain any ownership stake in the business post-close. In pain management acquisitions, seller notes of 10–15% of the purchase price are common and help bridge the gap between the SBA loan, buyer equity, and the full purchase price. The seller note also provides an alignment incentive for the selling physician to support a smooth transition of patient relationships and referral networks during the standby period. Always confirm seller note terms with your SBA lender before including them in the purchase agreement.
More Pain Management Clinic Guides
More SBA Loan Guides
Start Finding Pain Management Clinic Deals Today — Free to Join
Find SBA-eligible targets, score seller motivation, and get AI-written outreach in one platform.
Create your free accountNo credit card required